µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º Gc2sY 0
dK'?<w$
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ N"MK 0k
2GOQ| Z
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) V_f}Y8>e
# D"TY-$.=
1. ICAM-1 wuE] ju<
"&?F6Pi
2. interleukin 12(IL-12) la#f,C3_
2|]$hjs
3. tumor infiltrating lymphocyte Ug>yTc_(7
Eyi^N0
4. TCR/CD3 complex %7=B?c|
usEdp
5. hematopoietin receptor family %,f|H :+>u
z=1 J{]
6. individual idiotype(IdI) [kwVxaI
QX}O{LQR
7. integrin ,E,oz {,i(
?U'c;*O-
8. colony-stimulatory factor (CSF) @+II@[_lT
@IL_
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© l`c&nf6
d
|5V"U]W;
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? "@: b'm
P,5gaT)
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ Wr+?ul*_
VZ"W_U,
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠ7A0D[?^xe
,i KEIxA!
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ W*A-CkrO
H^y%Bi&^
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) On%21L;JG
g/H:`J
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ hAx#5@*5
(!kd9uV
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) a1V+doC
7/*Q?ic
3. immunoglobulin superfamily (IgSF) . ]
=$((
6zuWG0t
4. selectin Glz)-hjJ:n
3Z?"M
5. anti-idiotypic antibody (¦ÁId) *n9t~t6GHg
8r"$o1!
6. major histocompatibility complex(MHC) QLNQE 6-
aH@Ux?-}
7. immunotolerance K/oC+Z;K
Z}#,E;
8. biological reponse modifier(BRM) :e9}k5kdk
SQ*dC
9. immune reponse gene (Ir gene) l| 1O9I0Gd
$dr=M(&
10. reshaped antibody (or reconstituted antibody) t
;wfp>El
K$>C*?R
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© x13t@b
~ Iin|
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ G$X+g{
M%dJqwH5{
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? HsA4NRF'7
;CbQ}k
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ A`E7V}~
SM>
V
o+
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? 3#)I 7FG
S+c)
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ dP8b\H
2[WH8l+
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? yKJKQ9
r:h\{DVf
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ oqzx}?0
w+ZeVZv!r
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ sflH{!;p
!Pnvqgp/
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? nic7RN?F<
9NCo0!Fb
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ ImJ2tz6
A%H" a+
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ~Yrtz
*b+ef
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: %T:~N<8)
Kyy CS>
̉񧄤 ]
Lg$p
g70B22!y
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© ]IQTf5n
xA|72!zk0P
1. CD8 zZ3Ko3L%g_
C(i1 Vx<-
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) s;-(dQ{O
c`]_Q1'30w
3. immunoglobulin fold(Ig fold) f?O?2 g
'bN\8t\S
4. cadherin (Ca-dependent cell adhesion moleculers) mSSDV0Pfn
R
+H0+omj
5. idiotype-anti-idiotypic antibody immune network theory ,v;P@RL|g
>5Vv6_CI0?
6. HLA class II antigen 3D3/\E#'o
uW*)B_c
7. complementarity-determining region (CDR) Q[t|+RNKv2
sqkk4w1#C
8. perforin(or pore-forming protein ,PFP) Ew>E]Ys
4(5NHsvp
9. high affinity IL-2 receptor 5VWyc9Q
Dh=?Hzw
10. artificial active immunization .W_'6Q+
#.|efdsG
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© sJ{S(wpi"
Opc, {,z6
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦ÓᣠtOx)t$ix
/="~Jo
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 #l kv&.)x
[=dK%7v
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ N?]HWP^pg
i7hWBd4wK
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ N#(p_7M
Z(F`M;1>xI
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ L1'R6W~%dN
hS<lUG!9UJ
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? 0Z. b
d=H
Gt>*y.]
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£
9"T&P_
5Oh>r K(
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ 0E[&:6#Y
WCf?_\cG
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ W dM?{;
#
~.-o*
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ v#yeiE4
'Z^-(xG,+
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© qX,TX
3
.d
}7c!
1. immunoglobulin gene rearrangement Y
6B7qp
[nL{n bli
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) ,OGXH2!h
Pe-1o#7~W
3. flow cytometry(FCM) o5k7$0:t/
V4~`yT?*"
4. carrier effect <$ H-/~Y
JerueF;J
5. positive selection of T lymphocytes in thymus >ZX&2 {
'fIBJ3s[o
6. mouse TH1(Th1) and TH2(Th2) subsets (P=q&]l[
D\"F ?>
7. perforin (pore-forming protein ,PFP)
^)\z
*Fb|iR
8. ADCC(antibody-dependent cell-mediated cytotoxicity) VMa\?`fT
P LH
iQ:
9. SH-2(src-homology region 2) P&3Z,f0
g`NJ
`
10. Ab2¦Â (internal image) 2.6F5&:($
k|kn#X3X
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© 1-!q,q
.|Ee,Un
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? T/9`VB%N
u)NmjW
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? pb`!_GmB
W.|r=
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠb@p3iq:
X3# AYn,
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ MPS{MGVjbJ
0q4E^}iR
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦Óᣠ\R}`S`fIw`
1kDr;.m%
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) /a
'cP
4fuKpLA
ÃâÒßѧרҵ£º &IZthJqV
~
[wh
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ 76'vsg
a,EApUWw
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? 0P%,1M3d
*
11|P
´«È¾²¡Ñ§×¨Òµ£º Q+r8qnL'
0}:wM':G
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ @An "ClDa
MT?;9ZV}
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ ophQdJM
|IgH0
zZ
Ïû»¯×¨Òµ£º yn;sd+:z
~"t33U6
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ bq}hj Cy
?)2&L
Vrf
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? |J_kS90=
sC ^9
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ o`EL)K{
GK>. R<[
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 'T_Vm%
\)
*It`<F|
1. Fas(CD95)/FasL b5Sgf'B^
$Qc`4x;N
2. common chain of cytokine receptor zdh&,!] F6
YR\pt8(z?
3 . TCR/CD3 complex m%[Ul@!V
w QnW2)9!
4. negaive selection of thymocytes 42If/N?
2/coa+Qkv]
5. artificial active immune ;hcOD4or
6[{|'
6. anti-idiotypic ,{tK{XpS
^#Ruw?D
7. IgSF /Mg$t6vM
c-dOb.v0
8. Integrin tzKIi_2
K< ;I*cA
X
9. chemokine |v[0(
tt=JvI9>
10. B7/CD28 `wzb}"gLsM
Kpx(x0^2
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© )nI}K QJ<
1F*3K3T {
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ Vo@gxC,
`o;E
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ _3_kvs
ev$\Ns^g$3
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ M`~U
H\
sFvu@Wm'7W
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ )Td;2
ry2ZVIFa
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ 8H%-/2NW
3)bC,
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ Exy|^Dr0
gE_i#=bw
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© vzr?#FG
S1!X;PP/
1. B7/CD28 ^~iFG+g5
T@S\:P
2. Th1 subset Al0
i{.V
=`1#f
QDt
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© aR2Vvo
MPtn$@
4. antibody affinity maturation '
1jG?D
r&MHww1i
5. AP-1 S~ff<A>f
3p %B
6. single chain variable fragment£¨ScFv£© 4dB6
cg
5Dhpcgq<<
7. NK cell receptor `2B,+ytW8
`ZC{<eVJ}=
8. Zinkernagel-Doherty phenomenon #lf3$Tm D
{DI`HB[
9. Ig fold l\?HeVk^
&?#,rEw<x
10. CD40/CD40L cIm_~HH
gG 9e.++:
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© tfSY(cXg'T
`YK2hr
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ '
T
'&OA
R>r@I_
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ gH0'
Ok'
wc&`/'<p
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ c"pI+Q
,t2yw
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ @scy v@5)F
pd3=^Zi
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ xla64Qld
{.D^2mj|
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ %gd{u\h^
yFD3:;}
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ x)wlp{rLf
j,]KidDWm
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© JQo"<<[
WN5`zD$
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© q&:UP
dGNg[
1.Co-stimulators (or co-stimulating molecules) y7x&/2
(oftq!X2
2.NK-kB xT]|78h$
BE#s@-zR=p
3.Immunoglobulin superfamily
aJ4y%Gy?
U= Gw(
4.antigen-presenting cell (APC) &|d6
*ommU(r8
5.death domain 7,.3'cCL^
y<h~jz#hkq
6.CCR and CXCR ; qQ* p
hB!>*AsG
7.Lectin (or mitogen) c=^A3[AM
60iMfcT
8.Clusters of differentiation, CD) 0m,3''Q5lO
MYmH?A
9.B7 family `veq
/!
# },4m
10.Cytotoxic T lymphocyte, CTL) "u H VX|`
\i2S'AblYq
11.IL-15 and IL-15 receptor (IL-15R) q[wVC
h
@[s+5_9nk
12.MHC restriction Z
ZMz0^V
Yu`KHvur
13.Affinity-chromatography FEF $4)ROv
` 465
H
14.Cyctosprin A, CsA d,"6s=4(q
N!TC}#}l
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) l>J>?b=x"[
[8Yoz1(smA
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© zG|#__=
T
QrX 5Kwq
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 f\zu7,GU
^p2
_p9
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ v!~ ;QO
aOOkC&%
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ "lT>V)NB'
kzb%=EI
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© v<Ozr:lL
Vi5&%/Y
ÃâÒßѧרҵ£º UD+r{s/%
]rY3bG'&
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ iDdmr32E
~t,-y*=
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ N+V_[qr#
X^%E"{!nU
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ JKMcdD?'
(e~vrSk+)~
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) 6tDCaB
$1ZFkw
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) /Sn>{ &
)h&*b9[B=
1. ADCC(antibody dependent cell-mediated cytotoxicity) `(dRb
G#(+p|n
2. »·æß¾úËØ(cyclosporin) 1oVjx_I5y
d$O)k+j
3. KIR(killer cell inhibitory receptor) XY*KWO
OBBEsD/bc
4. HLDA(human leucocyte differentiation antigen) ^;xO-;q
KJ]ejb$
5. Interleukin 18(IL-18) xn`<g|"#
o@! !I w
6. ÕûºÏËØ(integrin) `& (Fy
yS2[V,vS7
7. Fas/FasL N:yyDeGyW
pSml+A:
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) 4[$D3,A
{
+.ai8
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) OlJkyL8|
n!>#o1Qr
10. Th1/Th2 B<A=U r
W2CQk
11. »ùÒòÒßÃç(DNAÒßÃç) N!hS`< }
o
D=6D9c?
12. chemokines and chemokine receptor uSRvc0R\
y,OwO4+y\
13. ÃâÒßÄÍÊÜ ^^{gn3xJ
nGdEJ
14. ¹²´Ì¼¤·Ö×Ó [Tq\K ^!^
YhzDi>hob
15. ËÀÍö½á¹¹Óò(death domain) ONkHHyT
\B<A.,i4
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) JnT1-=t.
p7YfOUo
k
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? %N, P?
,U
^z^ UFW
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óᣠf/&k$,
w
D}| 30s?u1
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î xzRs
;AXOp
%j[DG_
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ )/:&i<Q:
U/|H%b
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå SuHv{u45
P 3CzX48^
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ WG_20Jd
JY
eqL~h1^Co
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) --~m{qmy
zMXlLRC0
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ \:*<En0
{c3u!}mW
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ W:8*Z8?7
Pw"o[8
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£